Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
19.64
-0.46 (-2.29%)
Jul 2, 2026, 4:00 PM EDT - Market closed

Amphastar Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Amphastar Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of $22. The average 1-year stock price forecast is 12.02% higher than the current stock price, while the lowest is $19 (-3.26%) and the highest is $30 (+52.75%).

Price Target: $22 (+12.02%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$19$22$20.5$30
Change-3.26%+12.02%+4.38%+52.75%

Analyst Ratings

The average analyst rating for Amphastar Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy222100
Buy111100
Hold444576
Sell000001
Strong Sell000000
Total777777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Sell
Downgrades
$25$20
SellDowngrades$25$20+1.83%Jun 29, 2026
Barclays
Barclays
Hold
Reiterates
$23$20
HoldReiterates$23$20+1.83%Jun 3, 2026
Wells Fargo
Wells Fargo
Hold
Downgrades
$30$19
HoldDowngrades$30$19-3.26%May 14, 2026
Piper Sandler
Piper Sandler
Hold
Maintains
$25$21
HoldMaintains$25$21+6.92%May 11, 2026
Needham
Needham
Hold
Downgrades
n/a
HoldDowngradesn/an/aMay 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
744.06M
from 719.89M
Increased by 3.36%
Revenue Next Year
778.39M
from 744.06M
Increased by 4.61%
EPS This Year
2.63
from 3.25
Decreased by -19.20%
EPS Next Year
3.04
from 2.63
Increased by 15.75%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
437.77M498.99M644.40M731.97M719.89M744.06M
Revenue Growth
25.13%13.98%29.14%13.59%-1.65%3.36%
Gross Profit
199.74M248.86M351.12M373.86M356.06M365.33M
Gross Margin
45.63%49.87%54.49%51.08%49.46%49.10%
Operating Income
71.69M107.50M196.99M205.42M163.50M175.50M
Net Income
62.12M91.39M137.55M159.52M98.09M64.00M
EPS
----3.252.63
EPS Growth
-----15.80%-19.20%
Forward PE
16.9616.2920.779.427.787.48
Free Cash Flow
56.90M57.67M239.72M18.89M81.37M129.00M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High755.2M
Avg744.1M
Low730.6M

Revenue Growth

Revenue Growth202620272028
High
4.9%
Avg
3.4%
Low
1.5%

EPS Forecast

EPS202620272028
High2.94
Avg2.63
Low2.26

EPS Growth

EPS Growth202620272028
High
-9.6%
Avg
-19.2%
Low
-30.6%